Showing 2451-2460 of 2750 results for "".
- Online Consults On the Rise; Credentials Matterhttps://modernaesthetics.com/news/online-consults-on-the-rise-credentials-matter/2472967/The British Association of Aesthetic Plastic Surgeons (BAAPS) is reporting a “massive upswing” in demand for virtual consultations during lockdown, but urges the public to remain cautious. Despite predicted financial strains being felt acro
- Restylane Kysse Shows Positive Kissability Satisfaction in Phase 4 Studyhttps://modernaesthetics.com/news/restylane-kysse-shows-positive-kissability-satisfaction-in-phase-4-study/2472966/In a first-of-its-kind phase IV, Kissability study for an injectable hyaluronic acid (HA) lip filler, researchers evaluated subject satisfaction as well as partner satisfaction following treatment with Restylane Kysse. Many consumers report they often keep their lip treatments a
- Revance’s DaxibotulinumtoxinA for Injection Looks Good in Phase 2 Studies of Forehead Lines and Crow’s Feethttps://modernaesthetics.com/news/revances-daxibotulinumtoxina-for-injection-looks-good-in-phase-2-studies-of-forehead-lines-and-crows-feet/2472963/Revance Therapeutics, Inc.’s next-generation neuromodulator product, DaxibotulinumtoxinA, safely and effectively smoothed forehead lines and Crow’s feet with a median duration of 27 weeks in forehead lines and 24 weeks in crow’s feet achieved in at least one treatment group
- Endo’s Qwo Scores FDA Nod for Cellulite Treatmenthttps://modernaesthetics.com/news/endos-qwo-scores-fda-nod-for-cellulite-treatment/2472961/The FDA has given its nod to an entirely new way to address cellulite. Endo Aesthetic’s Qwo (collagenase clostridium histolyticum-aaes) is the first injectable treatment for moderate to severe cellulite of the buttocks in adult women. When fat in cellulite-prone areas swells and e
- Survey: Facial Plastic Surgeons Should Get Ready for the Zoom Boomhttps://modernaesthetics.com/news/survey-facial-plastic-surgeons-should-get-ready-for-the-zoom-boom/2472960/All of that Zoom has led to a boom in requests for facial plastic surgery, according to research published in The Journal of Facial Plastic Surgery and Aesthetic Medicine. The months spent on Zoom and other video conferencing services during the COVID-19 quarantine got a lot of
- CE Mark Plus Launch for System ONE-M from TOOsonix A/Shttps://modernaesthetics.com/news/ce-mark-plus-launch-for-system-one-m-from-toosonix-as/2472959/TOOsonix A/S is launching its CE-marked System ONE-M for color-independent tattoo removal, solar lentigines, spider veins, angiomas, telangiectasia and other aesthetic conditions. System ONE-M is a focused ultr
- Sciton’s New mJOULE Platform Features BBL HERO and MOXIhttps://modernaesthetics.com/news/scitons-new-mjoule-platform-features-bbl-hero-and-moxi/2472952/Sciton Inc. is rolling out their mJOULE dual-wavelength platform which includes a new fractional treatment, MOXI, and BBL HERO. MOXI delivers non-ablative laser energy to revitalize skin and BroadBand Light HERO (High Energy Rapid Output) allows practitioners to treat the entire body wi
- Obagi Rolls Out Two New Sunscreens and a Serumhttps://modernaesthetics.com/news/obagi-drops-two-new-sunscreens-and-a-serum-1/2472950/Obagi is launching two new Physical Defense Sunscreens and Daily Hydro-Drops. The new SUZANOBAGIMD Physical Defense Sunscreens, available in broad-spectrum SPF 40 and tinted SPF 50, defend against five light sources, including high energy visible light, or blue light, visible light
- ISHRS Survey: Brad Pitt, Eva Longoria Top List of Most-Desired Celebrity Lockshttps://modernaesthetics.com/news/brad-pitt-eva-longoria-top-list-of-most-desired-best-celebrity-locks/2472949/When it comes to celebrity hair, it’s Brad Pitt and Eva Longoria’s locks that are most admired, according to a
- Patients Treated with Dysport Highly Satisfied with Twice-Yearly Treatmentshttps://modernaesthetics.com/news/patients-treated-with-dysport-highly-satisfied-with-twice-yearly-treatments/2472933/Topline results of DREAM (Dysport Real-world Evaluation and Measured satisfaction study), a clinical study of Dysport (abobotulinumtoxinA) for injection, showed that 95 percent of patients treated with Dysport achieved high levels of satisfaction with two treatments per